Dyadic International Inc.
Dyadic International (DYAI) is a biotechnology company that focuses on developing and commercializing biopharmaceuticals and bio-based products using its proprietary C1 gene expression platform. This platform is designed to enable the efficient and cost-effective production of biologic products, including vaccines, antibodies, and enzymes, across various industries such as healthcare, agriculture, and industrial enzymes.